IP Library Granted Patent US 9,327,121
Granted Patent B2
US 9,327,121 · App. 13/607,617 · Granted May 3, 2016

Selective high frequency spinal cord modulation for inhibiting pain, including cephalic and/or total body pain with reduced side effects, and associated systems and methods

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,327,121
App. No.
13/607,617
Granted
May 3, 2016
Kind
B2
Abstract

Selective high-frequency spinal cord modulation for inhibiting pain with reduced side effects and associated systems and methods are disclosed. In particular embodiments, high-frequency modulation in the range of from about 1.5 KHz to about 100 KHz may be applied to the patient's spinal cord region from an epidural location to address phantom limb pain without creating paresthesia in the patient.

Claims (20)

1. A method for treating phantom limb pain in a patient, exclusive of phantom limb pain associated with total body pain, comprising:

configuring a signal generator to generate and deliver a phantom limb pain therapy signal to a target location of the patient's spinal cord from an epidural location via at least one implantable signal delivery device coupled to the signal generator,

wherein at least a portion of the therapy signal has a frequency in a frequency range of from 1.5 kHz to 100 kHz, includes pulses with a pulse width in a pulse width range of 10 microseconds to 333 microseconds, and has an amplitude in an amplitude range of 0.1 mA to 20 mA, which at least partially alleviates the phantom limb pain, exclusive of phantom limb pain associated with total body pain, without generating paresthesia in the patient.

2. The method of claim 1 wherein the therapy signal has a frequency of from about 5 kHz to about 15 kHz.

3. The method of claim 1 wherein the therapy signal has a frequency of from about 3 kHz to about 15 kHz.

4. The method of claim 1 wherein the therapy signal has a frequency of from about 3 kHz to about 20 kHz.

5. The method of claim 1 wherein the therapy signal has a frequency of from about 3 kHz to about 10 kHz.

6. The method of claim 1 wherein the therapy signal has a frequency of about 10 kHz.

7. The method of claim 1 wherein the target location is at a vertebral level of from about C2 to about C4 to treat phantom upper limb pain.

8. The method of claim 1 wherein the target location is at a vertebral level of from about T7 to about T10 to treat phantom lower limb pain.

9. The method of claim 1 wherein the target location is

(a) at a vertebral level of from about C2 to about C4 to treat phantom upper limb pain; or

(b) at a vertebral level of from about T7 to about T10 to treat phantom lower limb pain, or;

(c) both (a) and (b).

10. The method of claim 1 , wherein the at least one signal delivery device includes a percutaneous lead having one or more electrodes disposed toward a distal end of the percutaneous lead.

11. The method of claim 1 , wherein configuring the signal generator includes programming the signal generator.

12. The system of claim 1 , wherein the pulse width range is between 25 microseconds and 166 microseconds.

13. The method of claim 1 wherein the portion of the electrical therapy signal is biphasic.

14. The method of claim 1 wherein the pulse width range is 30 microseconds to 35 microseconds.

15. The method of claim 1 wherein the frequency range is 5 kHz to 15 kHz, the pulse width range is 30 microseconds to 35 microseconds, and the amplitude range is 0.5 mA to 10 mA.

Assignments (7)
RELEASE OF SECURITY INTEREST Recorded Apr 4, 2025
From: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS AGENT
To: NEVRO CORP.
Reel/Frame 070743/0001 →
PATENT SECURITY AGREEMENT Recorded Dec 1, 2023
From: NEVRO CORP.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS AGENT
Reel/Frame 065744/0302 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE NAME PREVIOUSLY RECORDED AT REEL: 029331 FRAME: 0978. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Jan 10, 2017
From: THACKER, JAMES R.; ALATARIS, KONSTANTINOS; GLINER, BRADFORD EVAN
To: NEVRO CORP.
Reel/Frame 041326/0825 →
RELEASE OF SECURITY INTEREST Recorded Jun 27, 2016
From: CRG SERVICING LLC
To: NEVRO CORP.
Reel/Frame 039168/0890 →
ASSIGNMENT AGREEMENT (REAFFIRMATION) Recorded Jun 13, 2016
From: CAPITAL ROYALTY PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "A" L.P.; PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.
To: CRG SERVICING LLC,
Reel/Frame 038984/0865 →
SECURITY INTEREST Recorded Dec 12, 2014
From: NEVRO CORP.
To: CAPITAL ROYALTY PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "A" L.P.; PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.
Reel/Frame 034619/0546 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 20, 2012
From: THACKER, JAMES R.; ALATARIS, KONSTANTINOS; GLINER, BRADFORD EVAN
To: NEVRO CORPORATION
Reel/Frame 029331/0978 →